Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Palinkas, Lawrence A.; Reedy, Kathleen R.; Smith, Mark; Anghel, Mihai; Steel, Gary D.; Reeves, Dennis; Shurtleff, David; Case, H. Samuel; Do, Nhan Van; Reed, H. Lester (2007)
Publisher: Co-Action Publishing
Journal: International Journal of Circumpolar Health
Languages: English
Types: Article
Subjects: clinical trial; cognition; cold; mood; thyroid hormones; tyrosine
OBJECTIVES: We previously reported that cognitive function improves with thyroxine and that there is a circannual pattern to mood and human TSH during Antarctic residence. To extend these findings, we examined the effects of tyrosine and a combined levothyroxine/liothyronine supplement in euthyroid men and women who spent the austral summer (n = 43) and/or winter (n = 42) in Antarctica. STUDY DESIGN: Randomized, placebo-controlled, clinical trial. METHODS: Subjects were randomized to receive the following each day for 91.6 +/- 3.2 days in summer and/or 138.0 +/- 3.2 days in winter: (1) 12g tyrosine mixed in 113g applesauce; (2) 50 microg of levothyroxine and 12.5 microg of liothyronine (T4-T3 Supplement); or (3) placebo. Cognitive performance and mood were assessed using the Automatic Neuropsychological Assessment Metric - Isolated and Confined Environments. RESULTS: With placebo in summer, mood did not change while TSH decreased by 28%; in winter, there was a 136% degradation in mood (p < 0.01) and TSH increased by 18%. With combined T4-T3 supplement, there was a 51% degradation in mood in summer compared with placebo (p < 0.05) and TSH decreased by 57%; in winter there was a 135% degradation in mood while TSH was reduced by 26% (p < 0.05). Tyrosine use in summer was associated with no change in mood and a 30% decline in TSH, while in winter there was a 47% improvement in mood and TSH decreased by 28% along with a 6% increase in fT3 (p < 0.05). CONCLUSIONS: Administration of tyrosine leads to a significant reduction in serum TSH and improvement in mood in winter compared with placebo, while the combined T4-T3 supplement leads to a worsening of mood in summer and no improvement in winter. There appears to be a seasonal influence on the psychological response to interventions and the relationship to changes in TSH reductions.Keywords: clinical trial; cognition; cold; mood; thyroid hormones; tyrosine(Int J Circumpolar Health 2007; 66(5):401-417)
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Do NV, LeMar H, Reed HL. Thyroid hormone responses to environmental cold exposure and seasonal change: a proposed model. Endocrinol Metab 1996;3:7-16.
    • 2. Harford RR, Reed HL, Morris MT, Sapien IE, Warden R, D'Alesandro MM. Relationship between changes in serum thyrotropin and total and lipoprotein cholesterol with prolonged Antarctic residence. Metabolism 1993;42:1159-1163.
    • 3. Reed HL, Ferreiro JA, Shakir KM, Burman KD, O'Brian JT. Pituitary and peripheral hormone responses to T3 administration during Antarctic residence. Am J Physiol 1988;254:E733-E739.
    • 4. Reed HL. Environmental influences upon thyroid hormone regulation. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott-Raven; 2000. p. 257-265.
    • 5. Savourey G, Barnavol B, Caravel JP, Feuerstein C, Bittel JH. Hypothermic general cold adaptation induced by local cold acclimation. Eur J Appl Physiol Occup Physiol 1996;73:237-244.
    • 6. Reed HL, Reedy KR, Palinkas LA, Do NV, Finney NS, Case HS, et al. Impairment in cognitive and exercise performance during prolonged Antarctic residence: effect of thyroxine supplementation in the Polar T3 syndrome. J Clin Endocrinol Metab 2001;86:110- 116.
    • 7. Reed HL, Silverman ED, Shakir KM, Dons R, Burman KD, O'Brian JT. Changes in serum triiodothyronine (t3) kinetics after prolonged Antarctic residence: the polar T3 syndrome. J Clin Endocrinol Metab 1990; 70:965-974.
    • 8. Reed HL, Brice D, Shakir KM, Burman KD, D'Alesandro MM, O'Brian JT. Decreased free fraction of thyroid hormones after prolonged Antarctic residence. J Appl Physiol 1990;69:1467-1472.
    • 9. Case HS, Reed HL, Palinkas LA, Reedy KR, Do NV, Finney NS, et al. Resting and exercise energy use in Antarctica: effect of 50% dietary restriction on the Polar T3 syndrome. Clin Endocrinol 2006;65:257-265.
    • 10. Hassi J, Sikkilä K, Ruokonen A, Leppäluoto J. The pituitary-thyroid axis in healthy men living under subarctic climatological conditions. J Endocrinol 2001;169:195- 203.
    • 11. Jackson I. Does thyroid hormone have a role as adjunctive therapy in depression? Thyroid 1996;6:63-67.
    • 12. Tamburini G, Tacconi P, Ferrigno P, Cannas A, Massa GM, Mastinu R, et al. Visual evoked potentials in hypothyroidism: a long-term evaluation. Electromyogr Clin Neurophysiol 1998;38:201-205.
    • 13. Monzani F, Del Gerra P, Caraccio N, Prunetti CA, Pucci E, Luisa M, et al. Subclinical hypothyroidism: neurobehavioural features and beneficial effect of L-thy - roxine treatment. Clin Investigat 1993;71:367-371.
    • 14. Kraus RP, Phoenix E, Edmonds MW, Nicholson IR, Chandarana PC, Tokmakejian S. Exaggerated TSH responses to TRH in depressed patients with “normal” baseline TSH. J Clin Psychiatry 1997;58:266-270.
    • 15. Palinkas LA, Reedy K, Shepanek M, Smith M, Anghel M, Steel GD, et al. Environmental influences on hypo - thalamic-thyroid function and behavior in Antarctica. Physiol Behav 2007;92:790-799.
    • 16. Palinkas LA, Cravalho M, Browner D. Seasonal variation of depressive symptoms in Antarctica. Acta Psychiatr Scand 1995;91:423-429.
    • 17. Coiro V, Volpi R, Marchisi C, De Ferri A, d'Amato L, Caffarri G, et al. Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder. Biol Psychiatry 1994;35:36-41.
    • 18. Sher L, Rosenthal, NE, Wehr TA. Free thyroxine and thyroid-stimulating hormone levels in patients with seasonal affective disorder and matched controls. J Affect Disord 1999;56:195-199.
    • 19. Bono G, Fancellu R, Blandini F, Santoro G, Mauri M. Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand 2004;110:59-66.
    • 20. Bunevičius R, Kažanavičius G, Žalinkevičius R, Prange A. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-429.
    • 21. Palinkas LA, Reed HL, Reedy KR, Do NV, Case HS, Finney NS. 2001. Circannual pattern of hypothalamicpituitary-thyroid (HPT) function and mood during extended Antarctic residence. Psychoneuroendocrinol 2001;26:421-431.
    • 22. Gibson CJ, Wurtman RJ. Physiological control of brain norepinephrine synthesis by brain tyrosine concentration. Life Sci 1978;22:1399-1406.
    • 23. Lieberman HR, Shukitt-Hale B. Food components and other treatments that may enhance mental performance at high altitudes and in the cold. In: Marriott BM, Carlson SJ, editors. Nutritional Needs in Cold and High-Altitude Environments. Washington, DC: National Academy Press; 1996. p. 453-465.
    • 24. Rauch TM, Lieberman HR. Tyrosine pretreatment reverses hypothermia-induced behavioral depression. Brain Res Bull 1990;24:147-150.
    • 25. Shurtleff D, Thomas JR, Ahlers ST, Schrot J. Tyrosine ameliorates a cold-induced delayed matching-to-sample performance decrement in rats. Psychopharmacol 1993;112(2-3):228-232.
    • 26. Shurtleff D, Thomas JR, Schrot J, Kowalski K, Harford R. Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacol Biochem Behav 1994;47: 935-941.
    • 27. D'Alesandro MM, Lopez A, Reed HL, Harford R. Indoor temperature variations in McMurdo, Antarctica. Antarct J US 1991;26:237-238.
    • 28. Reeves D, Kane R, Winter K. Automatic Neuropsychological Assessment Metrics (ANAM): Test Administrator's Guide Version 3.11 (Report No. NCRF-TR95-01). San Diego, CA: National Cognitive Recovery Foundation; 1995. 46pp.
    • 29. Smith A. Symbol Digit Modalities Test (SDMT) Manual-Revised. Los Angeles, CA: Western Psychological Services; 1988. 22pp.
    • 30. Humphrey DG, Kramer AF, Stanny RR. Influence of extended wakefulness on automatic and semiautomatic processing. Hum Factors 1994;36:652-669.
    • 31. Baddeley AD. A three-minute reasoning test based on grammatical transformation. Psychonomic Sci 1968; 10:341-342.
    • 32. Thomas JR, Ahlers ST, House JF, Schrot J. Repeated exposure to moderate cold impairs matching-to-sample performance. Aviat Space Environ Med 1989;60: 1063-1067.
    • 33. Sternberg S. Memory-scanning: mental processes revealed by reaction time experiments. Am Sci 1969; 57:421-457.
    • 34. Ryman DH, Biersner RJ, LaRocco JM. Reliabilities and validities of the mood questionnaire. Psychol Repts 1974;35:479-484.
    • 35. Xu C, z hu G, Xue QF, z hang S, Du G, Xi Y, et al. Effect of the Antarctic environment on hormone levels and mood of the 16th Chinese expeditioners. Int J Circumpolar Health 2003;62:255-267.
    • 36. Leppäluoto J, Korhonen I, Hassi J. Habituation of thermal sensations, skin temperatures, and norepinephrine in men exposed to cold air. J Clin Endocrinol Metab 2001;90:1211-1218.
    • 37. Leppäluoto J, Pääkkönen T, Korhonen I, Hassi J. Pituitary and autonomic responses to cold exposures in man. Acta Physiol Scand 2005;184:255-264.
    • 38. Defayolle M, Boutelier C, Bachelard C, Rivolier J, Taylor AJ. The stability of psychometric performance during the International Biomedical Expedition to the Antarctic (IBEA). J Human Stress 1985;11:157-160.
    • 39. Le Scanff C, Larue J, Rosnet E. How to measure human adaptation in extreme environments: the case of Antarctic wintering-over. Aviat Space Environ Med 1997;68:1144-1149.
    • 40. Palinkas LA, Houseal M. Stages of change in mood and behavior during a winter in Antarctica. Environ Behav 2000;32:129-142.
    • 41. Palinkas LA, Houseal M, Rosenthal NE. Subsyndromal seasonal affective disorder in Antarctica. J Nerv Ment Dis 1996;184:530-534.
    • 42. Fava M. The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression. J Clin Psychiatry 2003;64(Suppl 13):26-29.
    • 43. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000 (Suppl 1):2-19.
    • 44. Bianco A, Kim B. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest. 2006;116:2571-2579.
    • 45. Souêtre E, Salvati E, Candito M, Darcourt G. Biological clocks in depression: phase- shift experiments revisted. Eur Psychiatry 1991;6:21-29.
    • 46. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005;90:2666-2674.
    • 47. Clyde PW, Harari AE, Getka EJ, Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism. JAMA 2003;290:2952-2958.
    • 48. Siegmund W, Spieker K, Weike AI, Geissmann T, Modess C, Dabers T, et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol 2004;60:750-757.
    • 49. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996;11:744-749.
    • 50. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 2006;91:145-153.
    • 51. Schlote B, Nowotny B, Schaaf L, Kleinbohl D, Schmidt R, Teuber J, et al. Subclinical hyperthyroidism: physical and mental state of patients. Eur Arch Psychiatry Clin Neurosci 1992;241:357-364.
    • 52. Forman-Hoffman V, Philibert RA. Lower TSH and higher T4 levels are associated with current depressive syndrome in young adults. Acta Psychiatr Scand 2006;114:132-139.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Collected from